Should degenerated saphenous vein grafts routinely be sealed with drug-eluting stents?

Journal of Interventional Cardiology

Volumn 18, Issue 6, 2005, Pages 467-473

  Vermeersch, Paul ^a   Agostoni, Pierfrancesco ^a  

^a AZ Middelheim ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CONFERENCE PAPER; DEVICE; DRUG ELUTING STENT; HUMAN; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; TECHNIQUE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME; VEIN GRAFT DISEASE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SAPHENOUS VEIN; SIROLIMUS; STENTS;

EID: 28444479818     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2005.00087.x     Document Type: Conference Paper

References (35)

1. Fitzgibbon G, Kafka H, Leach A, et al. Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol 1996;28:616-626.
2. Weintraub WS, Jones EL, Morris DC, et al. Outcome of re-operative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation 1997;95:868-877.
3. Salomon N, Page U, Bigelow J, et al. Reoperative coronary surgery: Comparative analysis of 6591 patients undergoing primary bypass and 508 patients undergoing reoperative coronary artery bypass. J Thorac Cardiovasc Surg 1990;100:250-259.
4. De Feyter P, Van Suylen R, De Jaegere P, et al. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol 1993;21:1539-1549.
5. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-495.
6. Fischman DL, Leon MB, Bairn DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501.
7. Wong SC, Bairn DS, Schatz RA, et al. Immediate results and late outcomes after stent implantation in SVG lesions: The multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group. J Am Coll Cardiol 1995;26:704-712.
8. Savage M, Douglas J, Fischman D, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997;337:740-747.
9. Hanekamp C, Koolen J, Den Heijer P, et al. Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: The VENESTENT study. Catheter Cardiovasc Interv 2003;60:452-457.
10. Biondi-Zoccai GG, Agostoni P, Abbate A. Parallel hierarchy of scientific studies in cardiovascular medicine. Ital Heart J 2003;4:819-820.
11. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions: The task force for percutaneous coronary interventions of the European society of cardiology. Eur Heart J 2005;26:804-847.
12. Webb J, Carere R, Virmani R, et al. Retrieval and analysis of particulate debris following saphenous vein graft intervention. J Am Coll Cardiol 1999;34:461-467.
13. Bryan AJ, Angelini GD. The biology of saphenous vein graft occlusion: Etiology and strategies for prevention. Curr Opin Cardiol 1994;9:641-649
14. Depre C, Havaux X, Wijns W. Pathology of restenosis in spahenous bypass grafts after long term implantation. Am J Clin Pathol 1998;110:378-384.
15. Van Beusekom H, Van Der Giessen W, Van Suylen R, et al. Histology after stenting of human saphenous vein bypass grafts: Observations from surgically excised grafts 3 to 320 days after stent implantation. J Am Coll Cardiol 1993;21:45-54
16. Farb A, Sangiorgi G, Carter A, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44-52.
17. Baldus S, Koster R, Elsner M, et al. Treatment of aortocoronary vein graft lesions with membrane-covered stents: A multicenter surveillance trial. Circulation 2000;102:2024-2027.
18. Schachinger V, Hamm CW, Munzel T, et al. Investigators. A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts. J Am Coll Cardiol 2003;42:1360-1369.
19. Stankovic G, Colombo A, Presbitero P, et al. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial. Circulation 2003;108:37-42.
20. Buchbinder M. Eight-months results from the Symbiot III randomized SVG trial. Presented at Transcatheter Cardiovascular Therapeutics (TCT) 2004. Available at http://www. tctmd.com/csportal/appmanager/tctmd/main?_nfpb= true&_ pageLabel=TCTMDContent&hdCon=814445 Last accessed: 3 July 2005.
21. Stone G, Goldberg S, Mehran R, et al. A prospective, randomized U.S. trial of the PTFE-covered JOSTENT for the treatment of diseased saphenous vein grafts: The BARRICADE trial. J Am Coll Cardiol 2005;45(Suppl. A):27A (Abstract).
22. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorta-coronary bypass grafts. Circulation 2002;105:1285-1290.
23. Stone GW, Rogers C, Hermiller J, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorta-coronary bypass grafts. Circulation 2003;108:548-553.
24. Roffi M, Mukherjee D, Chew DP, et al. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: A pooled analysis of five randomized clinical trials. Circulation 2002;106:3063-3067.
25. Moses J, Leon M, Popma J, et al. SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
26. Stone GW, Ellis SG, Cox DA, et al. TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
27. Kastrati A, Mehilli J, Von Beckerath N, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis. A randomized controlled trial. JAMA 2005;293:165-171.
28. Ge L, Iakovou I, Sangiorgi G, et al. Treatment of saphenous vein graft lesions with drug eluting stents. J Am Coll Cardiol 2005;45:989-994.
29. Hoye A, Lemos PA, Arampatzis CA, et al. Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease. J Invasive Cardiol 2004;16:230-233.
30. Price M, Sawhney N, Madrid A, et al. Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions. Catheter Cardiovasc Interv 2005;65:208-211.
31. Zahn R, Hamm C, Schneider S, et al. Incidence and predictors of target vessel revascularization and clinical events rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German cypher stent registry). Am J Cardiol 2005;95:1302-1308.
32. Vermeersch P, Van Langenhove G, Convens C, et al. First randomized trial comparing sirolimus-eluting stents versus bare metal stents in severely diseased saphenous vein graft treatment: Six month clinical and angiographic outcome. J Am Coll Cardiol 2005;45(Suppl. A):84A (Abstract).
33. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-1521.
34. Ong AT, McFadden EP, Regar E, et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005;45:2088-2092.
35. Ellis SG, Brener SJ, DeLuca S, et al. Late myocardial ischemic events after saphenous vein graft intervention-importance of initially "nonsignificant" vein graft lesions. Am J Cardiol 1997;79:1460-1464.